PH22032A - 3-(piperidinyl) and 3-(pyrrolidinyl)-1h-indazoles, a method of treating psychoses and pain, pharmaceutical compositions containing the same - Google Patents
3-(piperidinyl) and 3-(pyrrolidinyl)-1h-indazoles, a method of treating psychoses and pain, pharmaceutical compositions containing the sameInfo
- Publication number
- PH22032A PH22032A PH31122A PH31122A PH22032A PH 22032 A PH22032 A PH 22032A PH 31122 A PH31122 A PH 31122A PH 31122 A PH31122 A PH 31122A PH 22032 A PH22032 A PH 22032A
- Authority
- PH
- Philippines
- Prior art keywords
- indazoles
- pyrrolidinyl
- piperidinyl
- pain
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52508883A | 1983-08-22 | 1983-08-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH22032A true PH22032A (en) | 1988-05-13 |
Family
ID=24091865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH31122A PH22032A (en) | 1983-08-22 | 1984-08-20 | 3-(piperidinyl) and 3-(pyrrolidinyl)-1h-indazoles, a method of treating psychoses and pain, pharmaceutical compositions containing the same |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0135781B1 (OSRAM) |
| JP (1) | JPS60100573A (OSRAM) |
| KR (1) | KR880002356B1 (OSRAM) |
| AT (1) | ATE47139T1 (OSRAM) |
| AU (1) | AU575846B2 (OSRAM) |
| CA (1) | CA1292232C (OSRAM) |
| DE (1) | DE3480091D1 (OSRAM) |
| DK (1) | DK400284A (OSRAM) |
| ES (2) | ES8601964A1 (OSRAM) |
| FI (1) | FI82242C (OSRAM) |
| GR (1) | GR80160B (OSRAM) |
| HU (1) | HU198036B (OSRAM) |
| IL (1) | IL72743A (OSRAM) |
| NZ (1) | NZ209279A (OSRAM) |
| PH (1) | PH22032A (OSRAM) |
| PT (1) | PT79110B (OSRAM) |
| ZA (1) | ZA846485B (OSRAM) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3563964D1 (en) * | 1984-10-16 | 1988-09-01 | Synthelabo | Piperidine derivatives, their preparation and their therapeutical application |
| DE3677609D1 (de) * | 1985-01-23 | 1991-04-04 | Hoechst Roussel Pharma | 3-piperidinyl- 1h-indazole, verfahren zu deren herstellung und deren anwendung als arzneimittel. |
| US4999356A (en) * | 1987-08-07 | 1991-03-12 | Hoechst-Roussel Pharmaceuticals, Inc. | 1-phenyl-3-(1-piperazinyl)-1H-indazoles |
| GB8811299D0 (en) * | 1988-05-12 | 1988-06-15 | Grayshan R | Indazole derivatives |
| US4957916A (en) * | 1988-08-05 | 1990-09-18 | Janssen Pharmaceutica N.V. | Antipsychotic 3-piperazinylbenzazole derivatives |
| NZ230045A (en) | 1988-08-05 | 1990-11-27 | Janssen Pharmaceutica Nv | 3-piperazinylbenzazole derivatives and pharmaceutical compositions |
| US5015740A (en) * | 1988-08-05 | 1991-05-14 | Janssen Pharmaceutica N.V. | Antipsychotic 3-piperazinylbenzazole derivatives |
| IL90879A0 (en) * | 1988-09-02 | 1990-02-09 | Janssen Pharmaceutica Nv | 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them |
| US5561128A (en) * | 1989-05-19 | 1996-10-01 | Hoechst-Roussel Pharmaceuticals, Inc. | N-[(4-(heteroaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility |
| US5364866A (en) * | 1989-05-19 | 1994-11-15 | Hoechst-Roussel Pharmaceuticals, Inc. | Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics |
| EP0402644B1 (en) * | 1989-05-19 | 1995-08-16 | Hoechst-Roussel Pharmaceuticals Incorporated | N-(aryloxyalkyl)heteroarylpiperidines and -heteroarylpiperazines,a process for their preparation and their use as medicaments |
| US5776963A (en) * | 1989-05-19 | 1998-07-07 | Hoechst Marion Roussel, Inc. | 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility |
| DK181190D0 (da) * | 1990-07-30 | 1990-07-30 | Lundbeck & Co As H | 3-aryl-indol- eller 3-aryl-indazolderivater |
| US5051430A (en) * | 1990-09-10 | 1991-09-24 | Hoechst-Roussel Pharmaceuticals Incorporated | 3-(1H-indazol-3-yl)-4-pyridinamines |
| NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
| DK55192D0 (da) * | 1992-04-28 | 1992-04-28 | Lundbeck & Co As H | 1-piperazino-1,2-dihydroindenderivater |
| ES2133416T3 (es) * | 1992-10-23 | 1999-09-16 | Merck Sharp & Dohme | Ligandos de subtipos de receptores de dopamina. |
| CA2146018A1 (en) * | 1992-10-23 | 1994-05-11 | Paul David Leeson | Dopamine receptor subtype ligands |
| DE4414113A1 (de) * | 1994-04-22 | 1995-10-26 | Merck Patent Gmbh | 3-Indolylpiperidine |
| US5668148A (en) * | 1995-04-20 | 1997-09-16 | Merck & Co., Inc. | Alpha1a adrenergic receptor antagonists |
| CZ130999A3 (cs) * | 1996-10-14 | 1999-07-14 | Bayer Aktiengesellschaft | Heterocyklylmethyl-substituované deriváty pyrazolu, způsob jejich výroby, farmaceutické prostředky tyto látky obsahující a jejich použití pro výrobu léčiv |
| FR2767827A1 (fr) * | 1997-09-03 | 1999-02-26 | Adir | Nouveaux derives de l'indole et de l'indazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| IL126745A (en) * | 1997-11-04 | 2003-09-17 | Pfizer Prod Inc | Methods of preparing 4-cyano-4- (substituted indazole) cyclohexanecarboxylic acids useful as pde4 inhibitors |
| US6133290A (en) * | 1998-07-31 | 2000-10-17 | Eli Lilly And Company | 5-HT1F agonists |
| WO2004069828A1 (ja) * | 2003-02-04 | 2004-08-19 | Mitsubishi Pharma Corporation | ピペリジン化合物およびその医薬用途 |
| CA2551346A1 (en) * | 2003-12-31 | 2005-07-21 | Warner-Lambert Company Llc | N-substituted piperidine and piperazine derivatives |
| JP4130219B2 (ja) | 2004-11-29 | 2008-08-06 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 治療用のピラゾロ［３，４−ｂ］ピリジンおよびインダゾール |
| WO2010043893A1 (en) * | 2008-10-14 | 2010-04-22 | Astrazeneca Ab | Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| PL2790687T3 (pl) | 2011-12-16 | 2019-03-29 | Poseida Therapeutics, Inc. | Modulatory trpc4 do stosowania w leczeniu lub zapobieganiu bólowi |
| JP2015214492A (ja) * | 2012-09-07 | 2015-12-03 | 大日本住友製薬株式会社 | ３−（４−ピペリジル）−インダゾール誘導体 |
| WO2018188590A1 (en) * | 2017-04-11 | 2018-10-18 | Sunshine Lake Pharma Co., Ltd. | Fluorine-substituted indazole compounds and uses thereof |
-
1984
- 1984-08-15 HU HU843095A patent/HU198036B/hu not_active IP Right Cessation
- 1984-08-17 DE DE8484109800T patent/DE3480091D1/de not_active Expired
- 1984-08-17 AT AT84109800T patent/ATE47139T1/de not_active IP Right Cessation
- 1984-08-17 EP EP84109800A patent/EP0135781B1/en not_active Expired
- 1984-08-20 NZ NZ209279A patent/NZ209279A/en unknown
- 1984-08-20 FI FI843281A patent/FI82242C/fi not_active IP Right Cessation
- 1984-08-20 PH PH31122A patent/PH22032A/en unknown
- 1984-08-20 ES ES535289A patent/ES8601964A1/es not_active Expired
- 1984-08-21 ZA ZA846485A patent/ZA846485B/xx unknown
- 1984-08-21 KR KR1019840005046A patent/KR880002356B1/ko not_active Expired
- 1984-08-21 PT PT79110A patent/PT79110B/pt not_active IP Right Cessation
- 1984-08-21 GR GR80160A patent/GR80160B/el unknown
- 1984-08-21 DK DK400284A patent/DK400284A/da not_active Application Discontinuation
- 1984-08-21 CA CA000461452A patent/CA1292232C/en not_active Expired - Lifetime
- 1984-08-21 JP JP59172528A patent/JPS60100573A/ja active Granted
- 1984-08-21 AU AU32250/84A patent/AU575846B2/en not_active Ceased
- 1984-08-28 IL IL72743A patent/IL72743A/xx unknown
-
1985
- 1985-05-16 ES ES543206A patent/ES8603867A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| KR880002356B1 (ko) | 1988-10-29 |
| ES535289A0 (es) | 1985-11-01 |
| ATE47139T1 (de) | 1989-10-15 |
| HU198036B (en) | 1989-07-28 |
| DE3480091D1 (en) | 1989-11-16 |
| FI843281A7 (fi) | 1985-02-23 |
| PT79110A (en) | 1984-09-01 |
| EP0135781A1 (en) | 1985-04-03 |
| ZA846485B (en) | 1985-03-27 |
| KR850001748A (ko) | 1985-04-01 |
| CA1292232C (en) | 1991-11-19 |
| NZ209279A (en) | 1988-05-30 |
| AU3225084A (en) | 1985-02-28 |
| PT79110B (en) | 1986-09-15 |
| ES543206A0 (es) | 1986-01-01 |
| JPS60100573A (ja) | 1985-06-04 |
| AU575846B2 (en) | 1988-08-11 |
| HUT37139A (en) | 1985-11-28 |
| EP0135781B1 (en) | 1989-10-11 |
| DK400284A (da) | 1985-02-23 |
| ES8603867A1 (es) | 1986-01-01 |
| FI82242B (fi) | 1990-10-31 |
| IL72743A0 (en) | 1984-11-30 |
| GR80160B (en) | 1984-12-19 |
| FI843281A0 (fi) | 1984-08-20 |
| IL72743A (en) | 1989-01-31 |
| DK400284D0 (da) | 1984-08-21 |
| JPH051792B2 (OSRAM) | 1993-01-11 |
| FI82242C (fi) | 1991-02-11 |
| ES8601964A1 (es) | 1985-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH22032A (en) | 3-(piperidinyl) and 3-(pyrrolidinyl)-1h-indazoles, a method of treating psychoses and pain, pharmaceutical compositions containing the same | |
| CS38989A2 (en) | Method of phenoxyacetamidoderivative production | |
| ES8405396A1 (es) | Procedimiento para la preparacion de 3-(1-sustituido-4-piperidil)-1,2-bencisoxazoles. | |
| EP0184389A3 (en) | Composition stably containing minocycline for treating periodontal diseases | |
| EP0043980A3 (en) | Polypeptides, process for their microbial production, intermediates therefor and compositions containing them | |
| PT72622A (en) | Novel carbostyril derivatives process for producing thereof and pharmaceutical composition containing the same | |
| PT78341B (en) | Process for the preparation of new 3-(3,4-di-hydroxyphenyl)-alanine phosphorilates derivatives and compositions for tanning containing then | |
| HU9402187D0 (en) | Heterocyclic compounds, process for producing them and pharmaceutical compositions containing them | |
| GR77706B (OSRAM) | ||
| GB2091999B (en) | Composition for treatment of psoriasis containing 10-substituted 1,8-dihydroxy-9-anthrones | |
| IL95245A0 (en) | Pharmaceutical compositions containing a certain carbazolone for the treatment of bulimia | |
| IL73829A (en) | Process for protecting keratinous material from insects by treatment with phenoxytrifluoromethane-sulfonanilides,certain such novel compounds and their preparation | |
| DE3171598D1 (en) | Novel beta-lactam compounds, process for production thereof, and medicines containing them | |
| ZA8708289D (en) | Pharmaceutical composition for treating arteriosclerosis | |
| PH25311A (en) | Method of treating psychostimulant addiction, pharmaceutical compositions containing same |